Artist Tiko Kerr pulls down a large cardboard box from a shelf in his East Vancouver studio. It’s overflowing with empty pill bottles. “These are my meds. This is what keeps me alive.” The prominent artist was nearly killed by HIV, the virus that causes AIDS. ADVERTISEMENT In 2005, existing treatments were failing and the virus was running rampant in his bloodstream.…
Read More
Accumulation of amyloid β protein (Aβ) due to increased generation and/or impaired degradation plays an important role in Alzheimer’s disease (AD) pathogenesis. In this report, we describe the identification of rare coding mutations in the endothelin-converting enzyme 2 (ECE2) gene in 1 late-onset AD family, and additional case-control cohort analysis indicates ECE2 variants associated with the risk of developing AD. The 2…
Read More
Canada’s Chief Science Advisor, Dr. Mona Nemer, was thrilled to receive 1,115 applications for her inaugural Youth Council. There is great enthusiasm among Canada’s youth population towards science and an eagerness to contribute to shaping the country’s science landscape. Below are the selected Chief Science Advisor’s Youth Council (CSA-YC) Members. The mandate of our Youth Council includes: Providing accurate and…
Read More
Three Faculty of Medicine researchers — Drs. Zachary Laksman, Bruce Verchere and Tim Kieffer — have collectively received more than $1.6M from the Stem Cell Network (SCN) to advance their work in stem cell and regenerative medicine research. The SCN investment, which will advance research collaborations across the country, aims to translate stem cell-based therapies from bench to bedside for…
Read More
Canadian researchers across the country have received funding to help spur their fight against a global pandemic. As nations grapple with the spread of COVID-19, work is underway to diagnose and treat the novel coronavirus, to limit its scope and to effectively deal with its fallout. The Star spoke to researchers from Halifax, Edmonton and Vancouver who are each doing their…
Read More
There are some things in life that often seem impossible while in the midst of doing it all: teaching a complicated subject, finding the right career that supports your research goals, and balancing your life, career and family. But Elitza Tocheva shares that no matter where you end up in your career, you never stop learning. That as a scientist, there’s…
Read More
AbCellera and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The collaboration will leverage AbCellera’s rapid pandemic response platform, developed under the DARPA Pandemic Prevention Platform (P3) Program, and Lilly’s global capabilities for rapid development,…
Read More
AbCellera, the antibody company, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2020 for its drug discovery platform that can search and analyze natural immune systems to deliver best-in-class antibody drugs. By innovating at every step of the discovery process, AbCellera’s team has repeatedly proven its ability to unlock novel targets, including those previously considered ‘undruggable’…
Read More
Mantle cell lymphoma (MCL) is an uncommon B-cell non-Hodgkin lymphoma (NHL) that is incurable with standard therapies. The genetic drivers of this cancer have not been firmly established and the features that contribute to differences in clinical course remain limited. To extend our understanding of the biological pathways involved in this malignancy, we performed a large-scale genomic analysis of MCL…
Read More

Viruses: Ancient, Tiny, Amazing

They’re as old as life itself but scientists can’t say for sure if they’re alive. They’re written into our DNA, shaping the human saga through mutation and resilience. We touch hundreds of millions of them every day. As the novel coronavirus outbreak disrupts global markets and prompts unprecedented containment measures, it is worth asking a very basic question: what, precisely,…
Read More